Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PharmaBridgeconsulting ApS
APS
Dissolved
CVR 44402777
Ådalsvej 225
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2023
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 541K
EBITDA margin
75.1%
Equity ratio
74.0%
Financial strength
Net profit 2024
DKK 314K
1 employees
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
DKK 541K
—
EBITDA
DKK 406K
—
Net profit
DKK 314K
—
Total assets
DKK 479K
—
Equity
DKK 354K
—
Employees
1
—
Company information
Legal name
PharmaBridgeconsulting ApS
CVR number
44402777
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
1. november 2023
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Contact
Address
Ådalsvej 225
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Odense
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
DKK thousands
Item
2024
Revenue
541
Staff expenses
-135
EBITDA
406
Depreciation & amort.
-0
EBIT
406
Net financials
-2
Profit before tax
405
Tax
91
Net profit
314
Balance sheet
DKK thousands
Item
2024
Total assets
479
Equity
354
Long-term debt
0
Short-term debt
124
Total debt
124
Financial ratios
5-year trend
EBITDA margin
75.1%
This company
15.8%
Market median
+375% vs market
2024
2024
Equity ratio
74.0%
This company
38.2%
Market median
+94% vs market
2024
2024
Return on equity
88.7%
This company
18.4%
Market median
+382% vs market
2024
2024
Net profit margin
58.0%
This company
8.1%
Market median
+616% vs market
2024
2024
Asset turnover
1.13×
This company
1.12×
Market median
+1% vs market
2024
2024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-11-01 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
AB
Arash Bakhshpour Larsen
Management
Management
2023 – 2026
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
F.A.M.L. Holding ApS
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of PharmaBridgeconsulting ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Arash Bakhshpour Larsen
Management
0 companies